Third Testosterone Replacement Therapy Bellwether trial to Begin on November 6, 2017

  • Taxotere Chemotheraphy Hair Loss Lawsuit - Medical Record Review | Neural IT

The third Testosterone Replacement Therapy bellwether lawsuit is scheduled to go before the jury on November 6 with Auxilium Pharmaceuticals as the defendant for their testosterone based Testim gel. The second Auxilium trial is set for April 9, 2018. Thousands of men have filed lawsuits against Testim gel maker, claiming failure to adequately warn about the potentially life-threatening injuries like heart attacks, stroke, pulmonary embolism, deep vein thrombosis and other blood clots, and death. The company had promoted Testim gel aggressively for the treatment of "Low T" symptoms. The gel works as a reservoir of testosterone that sticks to the skin and delivers the drug through the skin.


We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

Hurricane Relief Fund
We donated to Hurricane Relief Fund and got a signed ball from Kareem Abdul-Jabbar, the greatest
AAJ Annual Convention 2017
Neural IT sponsored TRT meeting was one of the active participants of AAJ Annual Convention 2017.
NJAJ Boardwalk Seminar 2017
Neural IT exhibited at the NJAJ Boardwalk Seminar 2017 held at Harrah's Resort, Atlantic City, NJ

Latest Tweets